1. Zelenay JL . The prescription drug user fee act: is a faster Food and Drug Administration always a better Food and Drug Administration? Food Drug L J (2005); 60: 266.
2. Ridgway WE . Realizing two-tiered innovation policy through drug regulation. Stan L Rev (2006); 58: 1225. [Hereinafter Ridgway].
3. Barbosa SA . Implementation of the DOHA declaration: its impact on American pharmaceuticals. Rutgers L J (2004); 36: 225. [Hereinafter Barbosa].
4. Beck JM, Azari ED . FDA, off-label use, and informed consent: debunking myths and misconceptions. Food Drug L J (1998); 53: 75. [Hereinafter Beck & Azari].
5. Beck & Azari, supra note 4, at 75, citing 21 C.F.R. §§ 314.1–314.560.